Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_assertion wasGeneratedBy ECO_0000203 NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_assertion wasDerivedFrom befree-2016 NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_assertion SIO_000772 8604810 NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_assertion evidence source_evidence_literature NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.
- NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_assertion description "[In fact, the ratio of BCL-2- to CgA-immunoreactive cells was reduced (median, 4.6%; p less than 0.0001; range, 0.9-42.0%) in sZES, a condition showing virtually no risk, unchanged (median, 55.6%; range 29.4-83.8 %) in cases of MEN-1/ZES with intermediate risk, and increased (median 87.6%; p less than 0.014; range, 48.8-199.4%) in cases of AFG, a condition at the highest risk of carcinoid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347634.RA3-WVs8hgosT63y6YAD1UWA1cPotF0P1JzVx-j8E6crc130_provenance.